Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cisplatin"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 106447

Starter badań:

Tytuł:
Selamectin increases cisplatin sensitivity by inhibiting cisplatin-resistant genes expression and autophagy in uveal melanoma.
Autorzy:
He J; Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200025, China; Institute of Translational Medicine, National Facility for Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China; Department of Ophthalmology, Shanghai Shibei Hospital of Jing'an District, Shanghai, 2000443, China.
Chen J; Department of Ophthalmology, Shanghai Shibei Hospital of Jing'an District, Shanghai, 2000443, China. Electronic address: .
Shen J; Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200025, China; Institute of Translational Medicine, National Facility for Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China. Electronic address: .
Pokaż więcej
Źródło:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2023 Jun 18; Vol. 661, pp. 75-81. Date of Electronic Publication: 2023 Apr 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cisplatin*/pharmacology
Uveal Neoplasms*/drug therapy
Animals ; Mice ; Mice, Nude ; Cell Line, Tumor ; Autophagy
SCR Disease Name:
Uveal melanoma
Czasopismo naukowe
Szczegóły
Tytuł:
Role and regulation of GLUT1/3 during oral cancer progression and therapy resistance.
Autorzy:
Kumari A; Department of Life Sciences, School of Natural Sciences, Central University of Jharkhand, Ratu-Lohardaga Road, Brambe, Ranchi 835205, Jharkhand, India.
Jha A; Department of Life Sciences, School of Natural Sciences, Central University of Jharkhand, Ratu-Lohardaga Road, Brambe, Ranchi 835205, Jharkhand, India.
Tiwari A; Department of Life Sciences, School of Natural Sciences, Central University of Jharkhand, Ratu-Lohardaga Road, Brambe, Ranchi 835205, Jharkhand, India.
Nath N; Department of Life Sciences, School of Natural Sciences, Central University of Jharkhand, Ratu-Lohardaga Road, Brambe, Ranchi 835205, Jharkhand, India.
Kumar A; Department of Biochemistry, All India Institute of Medical Sciences (AIIMS) Bhopal, Saket Nagar, Bhopal 462020, Madhya Pradesh, India.
Nagini S; Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar 608002, Tamil Nadu, India.
Mishra R; Department of Life Sciences, School of Natural Sciences, Central University of Jharkhand, Ratu-Lohardaga Road, Brambe, Ranchi 835205, Jharkhand, India. Electronic address: .
Pokaż więcej
Źródło:
Archives of oral biology [Arch Oral Biol] 2023 Jun; Vol. 150, pp. 105688. Date of Electronic Publication: 2023 Mar 22.
Typ publikacji:
Journal Article
MeSH Terms:
Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Mouth Neoplasms*/pathology
Humans ; Glucose Transporter Type 1/genetics ; Glucose Transporter Type 1/metabolism ; Drug Resistance, Neoplasm ; Cell Line, Tumor ; Neoplasm Recurrence, Local ; NF-kappa B/metabolism ; RNA, Messenger/metabolism ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Szczegóły
Tytuł:
Weekly versus 3-weekly cisplatin along with radiotherapy for locoregionally advanced non-nasopharyngeal head and neck cancers: Is the equipoise in literature addressed yet?
Autorzy:
Chatterjee S; Department of Oncology, Apollo Hospitals Navi Mumbai, Navi Mumbai, Maharashtra, India.
Kiyota N; Cancer Center, Kobe University Hospital, Kobe, Japan.
Vaish R; Tata Memorial Hospital, Parel, Mumbai, 400012, India.
Sharma A; All India Institute of Medical Sciences, New Delhi, India.
Tahara M; National Cancer Center Hospital East, Kashiwa, Japan.
Noronha V; Department of Medical Oncology, Tata Memorial Hospital and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Prabhash K; Department of Medical Oncology, Tata Memorial Hospital and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
D'Cruz A; Department of Oncology (Head and Neck Surgery), Apollo Hospitals Group, Chennai, India.
Pokaż więcej
Źródło:
Head & neck [Head Neck] 2023 Jun; Vol. 45 (6), pp. 1594-1603. Date of Electronic Publication: 2023 Apr 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cisplatin*/therapeutic use
Head and Neck Neoplasms*/drug therapy
Humans ; Chemoradiotherapy/methods ; Antineoplastic Combined Chemotherapy Protocols
Czasopismo naukowe
Szczegóły
Tytuł:
Augmented nephroprotective effect of liraglutide and rabeprazole via inhibition of OCT2 transporter in cisplatin-induced nephrotoxicity in rats.
Autorzy:
Sharaf G; Nasr Hospital Health Insurance, Helwan, Cairo, Egypt. Electronic address: .
E M EM; Pharmacology and Toxicology Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt. Electronic address: elmorsy_.
El-Sayed EK; Pharmacology and Toxicology Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt. Electronic address: elsayed_.
Pokaż więcej
Źródło:
Life sciences [Life Sci] 2023 May 15; Vol. 321, pp. 121609. Date of Electronic Publication: 2023 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
Cisplatin*/toxicity
Cisplatin*/metabolism
Liraglutide*/pharmacology
Liraglutide*/metabolism
Rats ; Animals ; Rabeprazole/pharmacology ; Kidney/metabolism ; Oxidative Stress ; Mitogen-Activated Protein Kinases/metabolism ; Apoptosis
Czasopismo naukowe
Szczegóły
Tytuł:
Cardioprotective and renoprotective effects of venlafaxine on cisplatin-induced cardiotoxicity and nephrotoxicity in rats.
Autorzy:
Ali MIM; Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Suez Canal University, 41522 Ismailia, Egypt. Electronic address: .
Imbaby S; Clinical Pharmacology Department, Faculty of Medicine, Suez Canal University, 41522 Ismailia, Egypt. Electronic address: samar_.
Arafat HEK; Histology & Cell Biology Department, Faculty of Medicine, Suez Canal University, 41522, Ismailia, Egypt.
Maher SA; Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Suez Canal University, 41522 Ismailia, Egypt.
Kolieb E; Medical Physiology Department, Faculty of Medicine, Suez Canal University, 41522 Ismailia, Egypt.
Ali SM; Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Suez Canal University, 41522 Ismailia, Egypt.
Pokaż więcej
Źródło:
Life sciences [Life Sci] 2023 May 01; Vol. 320, pp. 121561. Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Cisplatin*/toxicity
Cisplatin*/metabolism
Antineoplastic Agents*/toxicity
Antineoplastic Agents*/metabolism
Rats ; Animals ; Venlafaxine Hydrochloride/pharmacology ; Cardiotoxicity/metabolism ; Kidney/metabolism ; Antioxidants/pharmacology ; Antioxidants/metabolism ; Oxidative Stress ; Apoptosis
Czasopismo naukowe
Szczegóły
Tytuł:
ATM Inhibition-Induced ISG15/IFI27/OASL Is Correlated with Immunotherapy Response and Inflamed Immunophenotype.
Autorzy:
Huang CH; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Huang YC; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Xu JK; Department of Bioscience Technology, College of Health Science, Chang Jung Christian University, Tainan 711, Taiwan.
Chen SY; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Tseng LC; Department of Bioscience Technology, College of Health Science, Chang Jung Christian University, Tainan 711, Taiwan.
Huang JL; Department of Bioscience Technology, College of Health Science, Chang Jung Christian University, Tainan 711, Taiwan.
Lin CS; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.; Department of Biological Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Apr 30; Vol. 12 (9). Date of Electronic Publication: 2023 Apr 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Cisplatin*/metabolism
Neoplasms*/drug therapy
Neoplasms*/genetics
Neoplasms*/pathology
Humans ; Interferons/metabolism ; Immunotherapy/methods ; Tumor Microenvironment ; Ubiquitins/metabolism ; Cytokines/metabolism ; Membrane Proteins/metabolism ; Ataxia Telangiectasia Mutated Proteins/genetics ; Ataxia Telangiectasia Mutated Proteins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk factors associated with cisplatin-induced ototoxicity in Japanese patients with solid tumors.
Autorzy:
Okada H; Division of Medical Oncology, Kobe Minimally Invasive Cancer Center, Kobe, Japan.
Kitagawa K; Division of Medical Oncology, Kobe Minimally Invasive Cancer Center, Kobe, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 7904-7910. Date of Electronic Publication: 2022 Dec 25.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/adverse effects
Antineoplastic Agents*/therapeutic use
Cisplatin*/adverse effects
Cisplatin*/therapeutic use
Hearing Loss*/chemically induced
Hearing Loss*/diagnosis
Hearing Loss*/epidemiology
Neoplasms*/drug therapy
Ototoxicity*/diagnosis
Ototoxicity*/drug therapy
Tinnitus*/chemically induced
Tinnitus*/diagnosis
Tinnitus*/epidemiology
Aged ; Female ; Humans ; Male ; East Asian People ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis.
Autorzy:
Zeng Q; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.; Department of Obstetrics and Gynecology, Hubei Clinical Medicine Research Center for Individualized Cancer Diagnosis and Therapy, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.; Health Science Center, Yangtze University, Jingzhou, Hubei, China.
Yi C; Department of Obstetrics and Gynecology, Hubei Clinical Medicine Research Center for Individualized Cancer Diagnosis and Therapy, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Lu J; Department of Laboratory Medicine, Hubei Clinical Medicine Research Center for Individualized Cancer Diagnosis and Therapy, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Wang X; Department of Obstetrics and Gynecology, Hubei Clinical Medicine Research Center for Individualized Cancer Diagnosis and Therapy, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Chen K; Department of Obstetrics and Gynecology, Hubei Clinical Medicine Research Center for Individualized Cancer Diagnosis and Therapy, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Hong L; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 9024-9040. Date of Electronic Publication: 2023 Jan 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Neoplasm Proteins*/metabolism
Receptors, Cell Surface*/metabolism
Animals ; Female ; Humans ; Mice ; Cell Line, Tumor ; Computational Biology ; Drug Resistance, Neoplasm/genetics ; Gene Expression Regulation, Neoplastic ; Prognosis ; Tumor Microenvironment/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The effect of thymoquinone and propranolol combination on epidermoid laryngeal carcinoma cell.
Autorzy:
Şahin C; Department of Otolaryngology, Alanya Alaaddin Keykubat University School of Medicine, Antalya, Turkey.
Maytalman E; Department of Pharmacology, Alanya Alaaddin Keykubat University School of Medicine, Antalya, Turkey. .
Nemutlu Samur D; Department of Pharmacology, Alanya Alaaddin Keykubat University School of Medicine, Antalya, Turkey.
Doğan B; Microbiology Laboratory, Urla State Hospital, Ministry of Health, Izmir, Turkey.
Pokaż więcej
Źródło:
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2023 Jun; Vol. 280 (6), pp. 2849-2858. Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Cisplatin*/pharmacology
Carcinoma*
Humans ; Caspase 3/metabolism ; Cyclin D1/metabolism ; Propranolol/pharmacology ; Propranolol/therapeutic use ; bcl-2-Associated X Protein/genetics ; bcl-2-Associated X Protein/metabolism ; bcl-2-Associated X Protein/pharmacology ; Tumor Suppressor Protein p53/metabolism ; Cell Line, Tumor ; Apoptosis ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Proto-Oncogene Proteins c-bcl-2/pharmacology ; RNA, Messenger ; Cell Proliferation
Czasopismo naukowe
Szczegóły
Tytuł:
An anticancer Ti(IV) complex increases mitochondrial reactive oxygen species levels in relation with hypoxia and endoplasmic-reticulum stress: A distinct non DNA-related mechanism.
Autorzy:
Shpilt Z; Institute of Chemistry, the Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
Melamed-Book N; The Bio-Imaging Unit, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
Tshuva EY; Institute of Chemistry, the Hebrew University of Jerusalem, Jerusalem 9190401, Israel.. Electronic address: .
Pokaż więcej
Źródło:
Journal of inorganic biochemistry [J Inorg Biochem] 2023 Jun; Vol. 243, pp. 112197. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Cisplatin*/pharmacology
Ovarian Neoplasms*
Humans ; Female ; Reactive Oxygen Species ; Cell Line, Tumor ; Titanium ; Apoptosis ; Endoplasmic Reticulum Stress ; Hypoxia
Czasopismo naukowe
Szczegóły
Tytuł:
Endogenous production of ω-3 polyunsaturated fatty acids mitigates cisplatin-induced myelosuppression by regulating NRF2-MDM2-p53 signaling pathway.
Autorzy:
Xu Q; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China.
Zhang Z; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China.
Tang M; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China.
Xing C; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China.
Chen H; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China.
Zheng K; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China.
Zhao Z; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China.
Zhou S; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China.
Zhao AZ; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China.
Li F; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China. Electronic address: .
Mu Y; The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China. Electronic address: .
Pokaż więcej
Źródło:
Free radical biology & medicine [Free Radic Biol Med] 2023 May 20; Vol. 201, pp. 14-25. Date of Electronic Publication: 2023 Mar 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cisplatin*/toxicity
Fatty Acids, Omega-3*/pharmacology
Fatty Acids, Omega-3*/metabolism
Mice ; Animals ; NF-E2-Related Factor 2/genetics ; NF-E2-Related Factor 2/metabolism ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; Antioxidants/pharmacology ; Mice, Transgenic ; Signal Transduction
Czasopismo naukowe
Szczegóły
Tytuł:
Transcriptomic analysis reveals differential adaptation of colorectal cancer cells to low and acute doses of cisplatin.
Autorzy:
Saini H; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Pilani Campus, Rajasthan 333031, India. Electronic address: .
Dave R; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Pilani Campus, Rajasthan 333031, India. Electronic address: .
Chatterjee S; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Pilani Campus, Rajasthan 333031, India. Electronic address: .
Mandloi A; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Pilani Campus, Rajasthan 333031, India. Electronic address: .
Sharma H; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Pilani Campus, Rajasthan 333031, India. Electronic address: .
Daiya A; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Pilani Campus, Rajasthan 333031, India. Electronic address: .
Mukherjee S; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Pilani Campus, Rajasthan 333031, India. Electronic address: .
Chowdhury R; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Pilani Campus, Rajasthan 333031, India. Electronic address: .
Chowdhury S; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Pilani Campus, Rajasthan 333031, India. Electronic address: .
Pokaż więcej
Źródło:
Gene [Gene] 2023 May 15; Vol. 864, pp. 147304. Date of Electronic Publication: 2023 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Cisplatin*/therapeutic use
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Humans ; Transcriptome ; Drug Resistance, Neoplasm ; Gene Expression Profiling
Czasopismo naukowe
Szczegóły
Tytuł:
SORL1 stabilizes ABCB1 to promote cisplatin resistance in ovarian cancer.
Autorzy:
Zheng Z; Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People's Republic of China.
Li X; Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People's Republic of China.
Yang B; Department of Gynecologic Oncology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Xu Q; Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People's Republic of China.
Zhu X; Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People's Republic of China. zhuxl_.
Hu L; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 200240, Shanghai, People's Republic of China. .
Teng Y; Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, People's Republic of China. .
Pokaż więcej
Źródło:
Functional & integrative genomics [Funct Integr Genomics] 2023 May 05; Vol. 23 (2), pp. 147. Date of Electronic Publication: 2023 May 05.
Typ publikacji:
Journal Article
MeSH Terms:
Cisplatin*/pharmacology
Cisplatin*/therapeutic use
Cisplatin*/metabolism
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Humans ; Female ; Drug Resistance, Neoplasm/genetics ; Cell Line, Tumor ; ATP-Binding Cassette Transporters/genetics ; Adenosine Triphosphate ; LDL-Receptor Related Proteins/metabolism ; LDL-Receptor Related Proteins/pharmacology ; LDL-Receptor Related Proteins/therapeutic use ; Membrane Transport Proteins ; ATP Binding Cassette Transporter, Subfamily B/pharmacology ; ATP Binding Cassette Transporter, Subfamily B/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance.
Autorzy:
Liu L; Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China.
Chen C; Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Liu P; Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Li J; Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Pang Z; Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Zhu J; Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Lin Z; Department of Gynecological Oncology, The Memorial Hospital of Sun Yat-sen University, Guangzhou, 510000, China.
Zhou H; Department of Neurosurgery, Graduate School of Youjiang Medical University for Nationalities, Baise, Guangxi, 533000, China.
Xie Y; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China.
Lan T; Department of Neurosurgery, Liuzhou City People's Hospital, Guangxi, 545000, China.
Chen ZS; Institute for Biotechnology, College of Pharmacy and Health Sciences, St. John's University, NY, 11439, USA.
Zeng Z; Department of Gynecology, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China.
Fang W; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China.
Pokaż więcej
Źródło:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 May; Vol. 10 (14), pp. e2203423. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cisplatin*/pharmacology
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Female ; Humans ; Cell Proliferation/genetics ; Cell Transformation, Neoplastic ; Myosin Heavy Chains/genetics ; Myosin Heavy Chains/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
The protective effect of aspirin-induced temporary threshold shift in an animal model of cisplatin-related ototoxicity.
Autorzy:
Tzelnick S; Department of Otorhinolaryngology Head and Neck Surgery, Rabin Medical Center, 39 Jabotinsky St, Petah Tikva, Israel. .; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. .
Mizrachi A; Department of Otorhinolaryngology Head and Neck Surgery, Rabin Medical Center, 39 Jabotinsky St, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Barkan N; Institute of Audiology and Clinical Neurophysiology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Shivatzki S; Department of Otorhinolaryngology Head and Neck Surgery, Rabin Medical Center, 39 Jabotinsky St, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Yosefof E; Department of Otorhinolaryngology Head and Neck Surgery, Rabin Medical Center, 39 Jabotinsky St, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Hikri E; Department of Otorhinolaryngology Head and Neck Surgery, Rabin Medical Center, 39 Jabotinsky St, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Attias J; Institute of Audiology and Clinical Neurophysiology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.; Department of Communications Sciences and Disorders, Haifa University, Haifa, Israel.
Hilly O; Department of Otorhinolaryngology Head and Neck Surgery, Rabin Medical Center, 39 Jabotinsky St, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 May; Vol. 149 (5), pp. 2009-2016. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Journal Article
MeSH Terms:
Cisplatin*/toxicity
Ototoxicity*/etiology
Ototoxicity*/prevention & control
Mice ; Animals ; Aspirin/pharmacology ; Cochlea ; Disease Models, Animal
Czasopismo naukowe
Szczegóły
Tytuł:
Tumor volume reduction after induction chemotherapy with gemcitabine plus cisplatin in nasopharyngeal carcinoma.
Autorzy:
Chen Q; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.; National Clinical Research Center for Geriatric Disorders, Department of Geriatrics, Xiangya Hospital, Central South University, Changsha, China.
Shen L; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.; National Clinical Research Center for Geriatric Disorders, Department of Geriatrics, Xiangya Hospital, Central South University, Changsha, China.
Li S; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China. .; National Clinical Research Center for Geriatric Disorders, Department of Geriatrics, Xiangya Hospital, Central South University, Changsha, China. .
Pokaż więcej
Źródło:
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2023 May; Vol. 280 (5), pp. 2497-2509. Date of Electronic Publication: 2022 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
Cisplatin*/therapeutic use
Nasopharyngeal Neoplasms*/pathology
Humans ; Nasopharyngeal Carcinoma/pathology ; Gemcitabine ; Induction Chemotherapy ; Retrospective Studies ; Tumor Burden ; Deoxycytidine
Czasopismo naukowe
Szczegóły
Tytuł:
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it.
Autorzy:
Brock P; Department of Paediatric Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Meijer A; Department of Pediatric Oncology, Prinses Maxima Centrum, Utrecht, The Netherlands.
Kogner P; Department of Pediatric Oncology and Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, Sweden.
Ansari M; Pediatric Hematology and Oncology, Geneva University Hospital, Geneva, Switzerland.
Capra M; Paediatric Oncology, Our Lady's Children's Hospital, Dublin, Ireland.
Geller J; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Heuvel-Eibrink MVD; Department of Pediatric Oncology, Prinses Maxima Centrum, Utrecht, The Netherlands.
Knight K; Department of Pediatric Audiology, Oregon Health and Science University, Portland, Oregon, USA.
Kruger M; Department of Paediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa.
Lindemulder S; Department of Pediatric Oncology, Oregon Health and Science University, Portland, Oregon, USA.
Maibach R; Department of Statistics, International Breast Cancer Study Group, Bern, Switzerland.
O'Neill A; Children's Cancer and Blood Disorders Center, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
Papadakis V; Department of Pediatric Oncology, Agia Sofia Children's Hospital, Athens, Greece.
Rajput K; Department of Paediatric Audiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Bleyer A; Radiation Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
Bouffet E; Division of Pediatric Neuro-Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Sullivan M; Children's Cancer Centre and Department of Paediatric Oncology, Royal Children's Hospital, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 May; Vol. 70 (5), pp. e30248. Date of Electronic Publication: 2023 Feb 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cisplatin*/adverse effects
Antineoplastic Agents*/adverse effects
Child ; Humans ; Thiosulfates/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Molecular modeling for sensing of cisplatin drug by graphdiyne: electronic study via DFT.
Autorzy:
Kadhim MM; Department of Dentistry, Kut University College, Kut, Wasit, 52001, Iraq. Mustafa_.
Taha A; Pharmacy College, Al-Farahidi University, Baghdad, 10022, Iraq.
Mahal RK; College of Pharmacy, The University of Mashreq, 10021, Baghdad, Iraq.
Hachim SK; College of Technical Engineering, The Islamic University, Najaf, Iraq.; Department of Medical Laboratory, College of Health and Medical Technology, National University of Science and Technology, Thi-Qar, 64001, Iraq.
Abdullaha SA; Dijlah University College, Baghdad, 10022, Iraq.
Rheima AM; Department of Chemistry, College of Science, Mustansiriyah University, Baghdad, Iraq.
Pokaż więcej
Źródło:
Journal of molecular modeling [J Mol Model] 2023 Apr 05; Vol. 29 (5), pp. 129. Date of Electronic Publication: 2023 Apr 05.
Typ publikacji:
Journal Article
MeSH Terms:
Cisplatin*
Electronics*
Adsorption ; Electric Conductivity
Czasopismo naukowe
Szczegóły
Tytuł:
Cisplatin reacts with the RING finger domain of RNF11 and interferes with the protein functions.
Autorzy:
Wang Y; Department of Chemistry, University of Science and Technology of China, 96 Jinzhai Road, Hefei, Anhui 230026, China.
Yuan S; Department of Pharmacy, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230026, China.
Cao K; Department of Chemistry, University of Science and Technology of China, 96 Jinzhai Road, Hefei, Anhui 230026, China.
Liu Y; Department of Chemistry, University of Science and Technology of China, 96 Jinzhai Road, Hefei, Anhui 230026, China.; Department of Pharmacy, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230026, China.
Pokaż więcej
Źródło:
Metallomics : integrated biometal science [Metallomics] 2023 Apr 03; Vol. 15 (4).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cisplatin*/chemistry
RING Finger Domains*
Platinum/chemistry ; Sulfhydryl Compounds ; Zinc
Czasopismo naukowe
Szczegóły
Tytuł:
Flavonoids of Haloxylon salicornicum (Rimth) prevent cisplatin-induced acute kidney injury by modulating oxidative stress, inflammation, Nrf2, and SIRT1.
Autorzy:
Ramadan SA; Physiology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Kamel EM; Chemistry Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt.
Ewais MA; Physiology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Khowailed AA; Physiology Department, Faculty of Medicine, Cairo University, Giza, Egypt.
Hassanein EHM; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University-Assiut Branch, Asyut, Egypt.
Mahmoud AM; Department of Life Sciences, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK. .; Physiology Division, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt. .
Pokaż więcej
Źródło:
Environmental science and pollution research international [Environ Sci Pollut Res Int] 2023 Apr; Vol. 30 (17), pp. 49197-49214. Date of Electronic Publication: 2023 Feb 11.
Typ publikacji:
Journal Article
MeSH Terms:
Acute Kidney Injury*/chemically induced
Acute Kidney Injury*/prevention & control
Acute Kidney Injury*/pathology
Cisplatin*/toxicity
Flavonoids*/pharmacology
Amaranthaceae*/chemistry
Animals ; Rats ; Apoptosis ; Inflammation/chemically induced ; Inflammation/drug therapy ; Kelch-Like ECH-Associated Protein 1/metabolism ; Kidney ; NF-E2-Related Factor 2/metabolism ; NF-kappa B/metabolism ; Oxidative Stress/drug effects ; Reactive Oxygen Species/metabolism ; Sirtuin 1/metabolism
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 106447

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies